Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemiaAnne Ricksten, Björn Andréasson, Lars Palmqvist et al.|Haematologica|2008Cited by 39
Increased risk for vascular complications in PRV‐1 positive patients with essential thrombocythaemiaPeter Johansson, Björn Andréasson, Lovisa Wennström et al.|British Journal of Haematology|2003Cited by 30
The presence of a significant association between elevated PRV‐1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemiaPeter Johansson, Jack Kutti, Björn Andréasson et al.|European Journal Of Haematology|2003Cited by 21
Comparison of Methods for Polycythemia Rubra Vera-1 mRNA Quantification in Whole-Blood Leukocytes and Purified GranulocytesLars Palmqvist, Anne Ricksten, Philipp S. Goerttler et al.|Clinical Chemistry|2004Cited by 4
The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera.Peter Johansson, Björn Andréasson, Berit Johansson et al.|PubMed|2004Cited by 3